Day: May 20, 2021

NOT FOR DISTRIBUTION, RELEASE OR REPUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, RELEASE OR REPUBLICATION WOULD BE UNLAWFUL. Reference is made to the stock exchange announcement made by BW Ideol AS (the “Company”) on 5 May 2021, regarding the resolution to increase the share capital of the Company with NOK 41,732.70 through issuance of 417,327 new shares in order to satisfy the Company’s obligation to deliver shares following exercise of the greenshoe option. The share capital increase related to the issuance of these shares has now been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). Following such registration, the new share capital...

Recent Financial and Operating HighlightsStrong financial performance continued. In the first quarter, top and bottom line remained strong, as revenue increased by 63.9% year-over-year to RMB643.4 million (US$98.2 million) and net income turned positive for the first time and reached RMB58.2 million (US$8.9 million). Adjusted net income and adjusted EBITDA reached historical high and increased by 175.8% and 70.4% year-over-year to RMB109.3 million (US$16.7 million) and RMB307.8 million (US$47.0 million) respectively. Our adjusted EBITDA to interest ratio was 5.3 for the quarter. Released second annual ESG report, green effort continued to be recognized. On April 3, 2021, the Company released its second annual ESG report. Meanwhile, the Company’s green effort continued to be highly recognized in the industry. In the annual clean energy...

THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF NOTEHOLDERS. IF ANY NOTEHOLDER IS IN ANY DOUBT AS TO THE ACTION IT SHOULD TAKE, IT SHOULD SEEK ITS OWN FINANCIAL AND LEGAL ADVICE, INCLUDING AS TO ANY TAX CONSEQUENCES, IMMEDIATELY FROM ITS BROKER, BANK MANAGER, SOLICITOR, ACCOUNTANT OR OTHER INDEPENDENT FINANCIAL, TAX OR LEGAL ADVISER. G4S International Finance plc (incorporated with limited liability in England and Wales) (the Issuer) NOTICE OF SEPARATE MEETINGS of the holders of the following outstanding series of its notes  ISIN/ Common Code Nominal Amount Outstanding€500,000,000 1.50 per cent. Notes due 2023 of the Issuer guaranteed by G4S plc XS1515216650 / 151521665 €500,000,000€500,000,000 1.50 per cent. Notes due 2024 of the Issuer guaranteed by G4S plc XS1619992883 / 161999288 €500,000,000€550,000,000...

BEIJING, May 20, 2021 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced a strategic partnership with JD Health, a subsidiary of JD.com, Inc., and the largest online healthcare platform in China. The two companies aim to create innovative solutions for full-cycle cancer management. The partnership encompasses both online and offline components, and focuses on six key areas: consumer healthcare, digitization of liver disease management, government medical associations, sharing of customer screening resources, industry and user education, and consolidation of oncology doctors and experts on...

Greenwood Village, Colorado, May 20, 2021 (GLOBE NEWSWIRE) — Global Healthcare REIT, Inc. (Currently in a rebranding effort to Selectis Health, Inc.) (OTC: GBCS) (“Selectis” or the “Company”) today reported net income for the first quarter of 2021 of $240,566, or $0.01 per diluted share. Total revenue increased 149.6% to $5.76 million for the first quarter of 2021 compared to $3.85 million for the same period of 2020. FIRST QUARTER HIGHLIGHTSRecord revenue of $5,762,843 in 1Q21 versus revenue of $3,851,601 in 1Q20, a growth rate of 149.6% year-over-year; Net Income (loss) of $240,566 in 1Q21 versus net income of $53,600 in 1Q20, a growth rate of 448.8% year-over-year; Earnings (loss) per Share of $0.01 per share in 1Q21 versus net income of $0.00 per share in 1Q20, a growth rate of 100% year-over-year; Reopening...

Boston, May 20, 2021 (GLOBE NEWSWIRE) — Catastrophe modeling firm AIR Worldwide announced that newly established international insurance and reinsurance companies from the “Class of 2020,” have selected AIR as their modeler of choice to help manage their catastrophe risk. The so-called Class of 2020 is a group of insurance, reinsurance and specialty companies formed in 2020, including Conduit Re, Core Specialty, Inigo Ltd, Integral ILS Ltd, and Vantage Risk. AIR Worldwide is a Verisk (Nasdaq:VRSK) business. “As a pure play global reinsurance business with an ambition to write a profitable and well-diversified book of business, it was important for us to find a modeler who understood our needs and was able to offer sophisticated yet easy to use solutions to help manage our growing reinsurance portfolio,” said Trevor Carvey, CEO...

New agreement to supply 900 million doses to the European Commission (EC), with option to request up to an additional 900 million doses Additional dose deliveries beginning December 2021 through 2023 Pfizer and BioNTech have now committed a total of up to 2.4 billion doses of COMIRNATY® to the EC since the beginning of the pandemicNEW YORK AND MAINZ, GERMANY, May 20, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY®, the companies’ COVID-19 vaccine, to the European Union (EU), with an option for the EC to request up to an additional 900 million doses. This new agreement is in addition to the 600 million doses that have already been committed to the EU through 2021. The additional 900 million agreed doses are expected...